Geode Capital Management, LLC Enochian Biosciences Inc Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Enochian Biosciences Inc stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,572,290 shares of ENOB stock, worth $7.23 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,572,290

Previous 1,728,285 9.03%

Holding current value

$7.23 Million

Previous $7.95 Million 9.03%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	N/A	-155,995 Reduced 9.03%	1,572,290 $7.23 Million
Q2 2024 Aug 09, 2024	BUY	N/A	1,290,317 Added 294.61%	1,728,285 $7.95 Million
Q1 2024 May 13, 2024	BUY	N/A	75,559 Added 20.85%	437,968 $2.01 Million
Q4 2023 Feb 13, 2024	BUY	$4.3 - $4.7 $255,054 - $278,780	59,315 Added 19.57%	362,409 $1.67 Million
Q3 2023 Nov 13, 2023	BUY	$0.0 - $4.46 $0 - $656,659	147,233 Added 94.46%	303,094 $1.35 Million
Q2 2023 Aug 11, 2023	SELL	$0.4 - $1.3 $65,197 - $211,892	-162,994 Reduced 51.12%	155,861 $88,000
Q1 2023 May 15, 2023	BUY	$0.91 - $1.31 $65 - $94	72 Added 0.02%	318,855 $293,000
Q4 2022 Feb 13, 2023	BUY	$1.03 - $2.13 $127 - $264	124 Added 0.04%	318,783 $328,000
Q3 2022 Nov 14, 2022	SELL	$1.7 - $2.86 $598 - $1,006	-352 Reduced 0.11%	318,659 $576,000
Q2 2022 Aug 12, 2022	BUY	$1.93 - $8.73 $324,421 - $1.47 Million	168,094 Added 111.38%	319,011 $615,000
Q1 2022 May 13, 2022	SELL	$4.42 - $9.0 $9,582 - $19,512	-2,168 Reduced 1.42%	150,917 $1.25 Million
Q4 2021 Feb 11, 2022	SELL	$6.71 - $12.55 $365,580 - $683,761	-54,483 Reduced 26.25%	153,085 $1.12 Million
Q3 2021 Nov 12, 2021	BUY	$4.56 - $7.88 $271,361 - $468,930	59,509 Added 40.19%	207,568 $1.4 Million
Q2 2021 Aug 13, 2021	SELL	$2.94 - $6.79 $429,769 - $992,562	-146,180 Reduced 49.68%	148,059 $735,000
Q1 2021 May 12, 2021	BUY	$3.02 - $4.51 $30,819 - $46,024	10,205 Added 3.59%	294,239 $1.04 Million
Q4 2020 Feb 12, 2021	BUY	$2.82 - $3.55 $12,300 - $15,485	4,362 Added 1.56%	284,034 $837,000
Q3 2020 Nov 13, 2020	BUY	$3.42 - $4.55 $30,273 - $40,276	8,852 Added 3.27%	279,672 $1 Million
Q2 2020 Aug 13, 2020	BUY	$2.78 - $6.06 $40,921 - $89,203	14,720 Added 5.75%	270,820 $1.14 Million
Q1 2020 May 14, 2020	BUY	$2.08 - $5.41 $79,173 - $205,926	38,064 Added 17.46%	256,100 $768,000
Q4 2019 Feb 13, 2020	BUY	$3.48 - $6.75 $564,490 - $1.09 Million	162,210 Added 290.56%	218,036 $1.09 Million
Q3 2019 Nov 12, 2019	BUY	$3.95 - $5.72 $9,112 - $13,196	2,307 Added 4.31%	55,826 $307,000
Q2 2019 Aug 14, 2019	BUY	$4.5 - $6.99 $240,835 - $374,097	53,519 New	53,519 $240,000

Others Institutions Holding ENOB

# of Institutions

Shares Held

14.7M

Call Options Held

24K

Put Options Held

19.1K

View Full List

About Enochian Biosciences Inc

Ticker ENOB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,950,000
Market Cap $244M
Description
Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for au...

More about ENOB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Enochian Biosciences Inc Transaction History